In vitro selection and characterization of DNA aptamers specific for phospholamban

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 1, 2009, Pages 57-63

  Tanaka, Yoshie ^a   Honda, Takeshi ^a   Matsuura, Kenji ^a   Kimura, Yoshihiro ^a   Inui, Makoto ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; APTAMER 9; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO SELECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

APTAMERS, NUCLEOTIDE; BIOTIN; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; DNA; HEART; HUMANS; LIGANDS; MUSCLE, SKELETAL; MYOCARDIUM; PROTEIN BINDING; RECOMBINANT PROTEINS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SELEX APTAMER TECHNIQUE; SUBSTRATE SPECIFICITY;

EID: 63849135777     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.149526     Document Type: Article

References (33)

1. Blank M and Blind M (2005) Aptamers as tools for target validation. Curr Opin Chem Biol 9:336-342.
2. 2+-ATPase. J Biol Chem 267:26056-26061.
3. 2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J Biol Chem 282:20968-20976.
4. 2+-ATPase in a rat model of heart failure. Circulation 104:1424-1429.
5. Dieterle T, Meyer M, Gu Y, Belke DD, Swanson E, Iwatate M, Hollander J, Peterson KL, Ross J Jr, and Dillmann WH (2005) Gene transfer of a phospholamban- targeted antibody improves calcium handling and cardiac function in heart failure. Cardiovasc Res 67:678-688.
6. Eizema K, Fechner H, Bezstarosti K, Schneider-Rasp S, van der Laarse A, Wang H, Schultheiss HP, Poller WC, and Lamers JM (2000) Adenovirus-based phospho-lamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. Circulation 101:2193-2199.
7. Ellington AD and Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822.
8. Fleischer S and Inui M (1989) Biochemistry and biophysics ofexcitation-contraction coupling. Annu Rev Biophys Biophys Chem 18:333-364.
9. Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, et al. (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111:869-876.
10. Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW 2nd, MacLennan DH, et al. (2001) Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 276:24145-24152.
11. 2+-ATPase activity and cardiac myocyte contractility. Circulation 100:974-980.
12. Hoshijima M, Knöll R, Pashmforoush M, and Chien KR (2006) Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. J Am Coll Cardiol 48:A15-A23.
13. 2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. J Biol Chem 261:1794-1800.
14. 2+ pump of sarcoplasmic reticulum. Nature 342:90-92.
15. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R, Mariani JA, Pepe S, Chien KR, and Power JM (2007) Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 50:253-260.
16. 2+-ATPase of cardiac sarcoplasmic reticulum. Mol Pharmacol 61:667-673.
17. Kimura Y, Inui M, Kadoma M, Kijima Y, Sasaki T, and Tada M (1991) Effects of monoclonal antibody against phospholamban on calcium pump ATPase of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 23:1223-1230.
18. Lee JF, Stovall GM, and Ellington AD (2006) Aptamer therapeutics advance. Curr Opin Chem Biol 10:282-289.
19. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, and Kranias EG (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 75:401-409.
20. MacLennan DH and Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566 -577.
21. Mayer EJ, McKenna E, Garsky VM, Burke CJ, Mach H, Middaugh CR, Sardana M, Smith JS, and Johnson RG Jr (1996) Biochemical and biophysical comparison of native and chemically synthesized phospholamban and a monomeric phospholam- ban analog. J Biol Chem 271:1669 -1677.
22. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J Jr, Kranias EG, et al. (1999) Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99:313-322.
23. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, and Hajjar RJ (2000) Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 97:793-798.
24. Murphy MB, Fuller ST, Richardson PM, and Doyle SA (2003) An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Res 31:e110.
25. 2+ pump ATPase. J Biol Chem 267:1674-1679.
26. 2+ uptake in mammalian ventricular myocytes. Am J Physiol 261:H1344-H1349.
27. 2+ pump and blocking of phospholamban phosphorylation and dephosphorylation by a phospholamban monoclonal antibody. J Biol Chem 261:7018-7023.
28. Tada M and Inui M (1983) Regulation of calcium transport by the ATPase-phospholamban system. J Mol Cell Cardiol 15:565-575.
29. Tada M, Inui M, Yamada M, Kadoma M, Kuzuya T, Abe H, and Kakiuchi S (1983) Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′- monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 15:335-346.
30. Tada M and Katz AM (1982) Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol 44:401-423.
31. Tuerk C and Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510.
32. Zhai J, Schmidt AG, Hoit BD, Kimura Y, MacLennan DH, and Kranias EG (2000) Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 275:10538-10544.
33. Zvaritch E, Backx PH, Jirik F, Kimura Y, de Leon S, Schmidt AG, Hoit BD, Lester JW, Kranias EG, and MacLennan DH (2000) The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility. J Biol Chem 275:14985-14991.